<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anc Sci Life</journal-id><journal-id journal-id-type="iso-abbrev">Anc Sci Life</journal-id><journal-id journal-id-type="publisher-id">ASL</journal-id><journal-title-group><journal-title>Ancient Science of Life</journal-title></journal-title-group><issn pub-type="ppub">0257-7941</issn><issn pub-type="epub">2249-9547</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3800914</article-id><article-id pub-id-type="publisher-id">ASL-32-36</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>OA01.36. Management of diabetic retinopathy with doorvadya ghrita tarpana and internal administration of mahavasadi kwatha- a comparative study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Priyanka</surname><given-names>Rani</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Veeranagouda</surname><given-names>Adoor</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ramesh</surname><given-names>B N</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Dhiman</surname><given-names>K. S</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Manjusha</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><collab><italic>From</italic> 5th World Ayurveda Congress 2012 Bhopal, Madhya Pradesh, India. 7-10 Dec 2012</collab><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff id="aff1"><label>1</label>Deparment of Shalakya Tantra, I P G T &#x00026; R A, Gujarat Ayurved University, Jamnagar, Gujarat:361008,India</aff><aff id="aff2"><label>2</label>Professor and HOD, Department of Shalakya Tantra, Government Ayurvedic College, Bangalore</aff><aff id="aff3"/><pub-date pub-type="ppub"><month>12</month><year>2012</year></pub-date><volume>32</volume><issue>Suppl 1</issue><fpage>S36</fpage><lpage>S36</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2012 Rani Priyanka; licensee Ancient Science of Life.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</uri>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Purpose:</title><p>A comparative clinical study was conducted on the management of Diabetic Retinopathy (DR) with Doorvadya Ghrita Tarpana and Mahavasadi kwatha internally. The main aim and objective of the study was to evaluate the efficacy of Doorvadya ghrita Tarpana and Mahavasadi kwatha internally, when used individually and as an adjuvant.</p></sec><sec id="st2"><title>Method:</title><p>The patients were randomly divided in 3 groups with 15 patients in each group. Group A: Tarpana with Doorvadya Ghrita for 3 sittings, 5 days in each sitting, with a gap of 11 days after each sitting, total 48 days duration. Group B: Mahavasakadi Kwatha Pana with 50ml dose every day in the morning, empty stomach, for 48 days. Group C: Both Doorvadya Ghrita Tarpana and Mahavasakadi kwatha pana, for 48 days.</p></sec><sec id="st3"><title>Result:</title><p>All the three groups have shown statistically significant results. Group B and C have shown better response as compared to Group A. Moreover Group B has shown slightly better response as compared to Group C.</p></sec><sec id="st4"><title>Conclusion:</title><p>The study showed that microaneurysms, intra retinal haemorrhages, exudates are best managed by treatment with Group-B; where as blurred vision responded better to combine treatment of Group-C. Other parameters like neovascularization did not produce any significant result in any of the groups. Hence Ayurvedic management definitely prevents further progression of the Diabetic Retinopathy and its complications.</p></sec></abstract></article-meta></front></article>